Reteplase superior to alteplase within 4.5 hours of ischemic stroke
Jun 20, 2024
Reteplase was more likely to result in excellent functional outcome than alteplase for ischemic stroke within 4.5 hours of symptom onset.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Low-dose direct oral anticoagulants tied to more bleeding episodes
Jun 19, 2024
The findings compared with standard doses in patients with atrial fibrillation.
Semaglutide cuts risk for kidney outcomes, death in CKD with T2DM
May 31, 2024
A reduction was seen in risk for clinically important kidney outcomes and death from cardiovascular causes.
Semaglutide boosts kidney outcomes with obesity + cardiovascular disease
May 28, 2024
At the prespecified 104-week time point, semaglutide was associated with a lesser decline in eGFR than placebo.
Antihypertensives linked to eczematous dermatitis in seniors
May 24, 2024
The largest effect sizes were seen for diuretics and calcium channel blockers, and the smallest were seen for ACE inhibitors and beta-blockers.
Oldest adults with acute myeloid leukemia benefit from Venetoclax
May 16, 2024
Octogenarians and nonagenarians can be treated successfully with VEN-HMA.
Following drop after COVID-19 onset, inappropriate antibiotic prescribing is up
May 01, 2024
An initial decrease was seen in proportion with inappropriate prescription, followed by a subsequent increase.
Reduced vancomycin susceptibility tied to poorer C. diff outcomes
Apr 30, 2024
Poorer outcomes were seen for 30-day sustained clinical response and 14-day initial cure rates.
Antibiotics not helpful for cough due to lower respiratory tract infection
Apr 25, 2024
Despite patient beliefs, no effect was seen on the severity or duration of the cough.